A Phase II Study of Docetaxel Plus Carboplatin in Hormone Refractory Prostate Cancer Patients Refractory to Prior Docetaxel-Based Chemotherapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Docetaxel
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2009 Biomarkers information updated
- 16 Jan 2008 The expected completion date for this trial is now 1 Apr 2008.